I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, I..:
Otávio Augusto Chaves
;
Carolina Q. Sacramento
;
André C. Ferreira
...
Medicinal Chemistry. , 2021
Link:
https://doi.org/10.3390/ph15010021
RT Journal T1
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
UL https://suche.suub.uni-bremen.de/peid=base-ftmdpi:oai:mdpi.com:_1424-8247_15_1_21_&Exemplar=1&LAN=DE A1 Otávio Augusto Chaves A1 Carolina Q. Sacramento A1 André C. Ferreira A1 Mayara Mattos A1 Natalia Fintelman-Rodrigues A1 Jairo R. Temerozo A1 Leonardo Vazquez A1 Douglas Pereira Pinto A1 Gabriel P. E. da Silveira A1 Laís Bastos da Fonseca A1 Heliana Martins Pereira A1 Aluana Santana Carlos A1 Joana C. d'Avila A1 João P. B. Viola A1 Robson Q. Monteiro A1 Patrícia T. Bozza A1 Hugo Caire Castro-Faria-Neto A1 Thiago Moreno L. Souza PB Multidisciplinary Digital Publishing Institute YR 2021 K1 SARS-CoV-2 K1 COVID-19 K1 repurposing drugs K1 atazanavir K1 protease inhibitor K1 pharmacokinetics K1 molecular docking JF Medicinal Chemistry LK http://dx.doi.org/https://doi.org/10.3390/ph15010021 DO https://doi.org/10.3390/ph15010021 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)